Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Clinical trial NCT06534424 · COMPLETED

Trial details

NCT number: NCT06534424
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

Start date: 2018-01-01
Primary completion: 2023-09-30
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.